Medicare Enrolled
Dr. Kevin McKian
Internal Medicine · Rolling Meadows, IL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. McKian from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. McKian?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. McKian
Dr. Kevin McKian is an internal medicine specialist in Rolling Meadows, IL, with 19 years of NPI registration. Based on federal Medicare data, Dr. McKian performed 72,810 Medicare services across 2,685 unique beneficiaries.
Between the years covered by Open Payments, Dr. McKian received a total of $15,860 from 77 pharmaceutical and/or device companies across 597 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. McKian is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 0% volume in IL
$15,860 industry payments
Medicare Practice Summary
Medicare Utilization ↗72,810
Medicare services
Top 0% in IL for internal medicine
2,685
Unique beneficiaries
$7
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~3,832 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
35,250 | $1 | $2 |
| Injection, granisetron, extended-release, 0.1 mg | 8,900 | $6 | $10 |
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
8,440 | $2 | $9 |
| Anti-nausea injection (aprepitant) | 4,810 | $1 | $4 |
| Denosumab injection (Prolia/Xgeva) | 3,660 | $18 | $39 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
2,526 | $0 | $2 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,346 | $8 | $55 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
1,113 | $10 | $65 |
| Anti-nausea injection (ondansetron/Zofran) | 792 | $0 | $9 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
733 | $93 | $289 |
| Magnesium sulfate injection, per 500 mg An injection of magnesium sulfate administered in 500 mg increments. |
454 | $1 | $6 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
439 | $144 | $335 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
381 | $24 | $135 |
| Immunoglobulin level test A blood test that measures the level of gammaglobulins, which are immune system proteins. |
321 | $9 | $40 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
319 | $108 | $488 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
293 | $7 | $55 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
219 | $13 | $74 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
217 | $61 | $176 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
213 | $12 | $68 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
171 | $13 | $85 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
156 | $53 | $230 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 137 | $20 | $200 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
113 | $66 | $165 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
105 | $23 | $129 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
104 | $28 | $114 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 104 | $134 | $1,912 |
| Iron level test | 93 | $6 | $50 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
93 | $9 | $35 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
93 | $66 | $190 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
87 | $16 | $93 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
82 | $19 | $100 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
80 | $1 | $6 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
79 | $11 | $65 |
| PSA test (prostate cancer screening) | 74 | $18 | $97 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
73 | $6 | $48 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
69 | $54 | $249 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
67 | $17 | $90 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
60 | $1 | $12 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
57 | $3 | $10 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
56 | $4 | $20 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
44 | $14 | $80 |
| CA 19-9 tumor antigen test A blood test that measures the level of CA 19-9, a substance that can be found in the blood of some people with cancer. This quantitative analysis detects and measures the specific tumor antigen. |
44 | $20 | $200 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
44 | $125 | $390 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
43 | $144 | $429 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 125 | 40 | $20 | $134 |
| New patient office visit, complex (60-74 min) | 28 | $182 | $495 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
26 | $109 | $327 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
26 | $2 | $19 |
| Free thyroxine (T4) test A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream. |
24 | $9 | $115 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
22 | $72 | $78 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
22 | $32 | $50 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
21 | $27 | $189 |
| Phosphate level test A blood test that measures the amount of phosphate in your body. Phosphate is a mineral that helps keep bones and teeth strong. |
18 | $5 | $30 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
17 | $8 | $55 |
| Total T3 thyroid hormone test A blood test that measures the total amount of triiodothyronine (T3) hormone in your body. T3 is a thyroid hormone that helps regulate metabolism and energy levels. |
12 | $14 | $180 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
49.9% high complexity
41.9% medium
8.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$15,860
Total received (2018-2024)
Avg $2,266/year across 7 years
Top 5% in IL for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
77
Companies
597
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,279 (71.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$4,045 (25.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$536 (3.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,150
2023
$2,376
2022
$1,775
2021
$1,270
2020
$2,617
2019
$1,606
2018
$4,066
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$241
Novartis Pharmaceuticals Corporation
$227
Genentech USA, Inc.
$154
ABBVIE INC.
$154
AstraZeneca Pharmaceuticals LP
$118
Celgene Corporation
$104
Eisai Inc.
$88
Merck Sharp & Dohme LLC
$85
E.R. Squibb & Sons, L.L.C.
$68
Gilead Sciences, Inc.
$67
Incyte Corporation
$66
Lilly USA, LLC
$60
Blueprint Medicines Corporation
$53
EMD Serono, Inc.
$51
SERVIER PHARMACEUTICALS LLC
$49
Deciphera Pharmaceuticals Inc.
$48
Janssen Biotech, Inc.
$45
GENZYME CORPORATION
$44
Daiichi Sankyo Inc.
$44
GlaxoSmithKline, LLC.
$38
TAIHO ONCOLOGY, INC.
$38
Astellas Pharma US Inc
$35
Kite Pharma, Inc.
$31
Apellis Pharmaceuticals, Inc.
$31
Alexion Pharmaceuticals, Inc.
$28
Dendreon Pharmaceuticals LLC
$25
Fennec Pharmaceuticals, Inc.
$25
Mirati Therapeutics, Inc.
$22
Agios Pharmaceuticals, Inc.
$22
Stemline Therapeutics Inc.
$20
BeiGene USA, Inc.
$19
TerSera Therapeutics LLC
$17
Pharmacosmos Therapeutics Inc.
$16
GE HEALTHCARE
$15
Top 3 companies account for 28.9% of 2024 payments
All-time payments by company (2018-2024) ›
TESARO, Inc.
$2,384
BeiGene USA, Inc.
$2,019
Novartis Pharmaceuticals Corporation
$992
AstraZeneca Pharmaceuticals LP
$784
PFIZER INC.
$749
Genentech USA, Inc.
$721
E.R. Squibb & Sons, L.L.C.
$696
Merck Sharp & Dohme Corporation
$510
Seagen Inc.
$491
Celgene Corporation
$431
Lilly USA, LLC
$385
Merck Sharp & Dohme LLC
$384
Amgen Inc.
$275
Janssen Biotech, Inc.
$265
Janssen Pharmaceuticals, Inc
$241
Daiichi Sankyo Inc.
$235
Gilead Sciences, Inc.
$227
EMD Serono, Inc.
$216
Pharmacyclics LLC, An AbbVie Company
$208
ABBVIE INC.
$205
Takeda Pharmaceuticals U.S.A., Inc.
$198
SANOFI-AVENTIS U.S. LLC
$188
GENZYME CORPORATION
$161
Eisai Inc.
$150
Seattle Genetics, Inc.
$146
Astellas Pharma US Inc
$143
Incyte Corporation
$142
Janssen Scientific Affairs, LLC
$125
Alexion Pharmaceuticals, Inc.
$125
Blueprint Medicines Corporation
$95
JAZZ PHARMACEUTICALS INC.
$94
Coherus Biosciences Inc.
$94
Regeneron Healthcare Solutions, Inc.
$91
Bayer HealthCare Pharmaceuticals Inc.
$88
Boehringer Ingelheim Pharmaceuticals, Inc.
$87
G1 Therapeutics, Inc.
$81
MorphoSys, US Inc.
$76
SERVIER PHARMACEUTICALS LLC
$71
TAIHO ONCOLOGY, INC.
$68
Mirati Therapeutics, Inc.
$64
EISAI INC.
$64
AMAG Pharmaceuticals, Inc.
$60
GlaxoSmithKline, LLC.
$56
TerSera Therapeutics LLC
$51
Deciphera Pharmaceuticals Inc.
$48
Kite Pharma, Inc.
$47
Helsinn Therapeutics (U.S.), Inc.
$46
Stemline Therapeutics Inc.
$45
CTI BioPharma Corp.
$45
Puma Biotechnology, Inc.
$42
Agios Pharmaceuticals, Inc.
$41
SOBI, INC
$40
Pharmacosmos Therapeutics Inc.
$35
Exelixis Inc.
$35
Clovis Oncology, Inc.
$33
Taiho Oncology, Inc.
$31
Apellis Pharmaceuticals, Inc.
$31
ARRAY BIOPHARMA INC
$31
Global Blood Therapeutics, Inc.
$29
GE HealthCare
$29
Dendreon Pharmaceuticals LLC
$25
Fennec Pharmaceuticals, Inc.
$25
Servier Pharmaceuticals LLC
$24
Jazz Pharmaceuticals Inc.
$22
Karyopharm Therapeutics Inc.
$21
Ipsen Biopharmaceuticals, Inc
$21
Pharmacyclics LLC, an AbbVie Company
$20
Lexicon Pharmaceuticals, Inc.
$20
Epizyme, Inc.
$20
Epizyme, Inc.,
$19
Amneal Pharmaceuticals LLC
$17
PORTOLA PHARMACEUTICALS, INC.
$17
GE HEALTHCARE
$15
ImmunoGen, Inc.
$14
Midatech Pharma US Inc
$14
Fortovia Therapeutics, Inc.
$13
Dova Pharmaceuticals
$12
Top 3 companies account for 34.0% of all-time payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AKYNZEO · ALIMTA · ALUNBRIG · AVASTIN · AYVAKIT · Abraxane · Alecensa · Avastin · BAVENCIO · BEVYXXA · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · CABLIVI · CALQUENCE · COSELA · CYRAMZA · Cabometyx · Columvi · DARZALEX · Doptelet · ELAHERE · ELIQUIS · ELITEK · ELREXFIO · ENHERTU · EPKINLY · ERLEADA · Elahere · Empaveli · Enhertu · Erleada · FERAHEME · Fabhalta · GAZYVA · GILOTRIF · Gelclair · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · JAKAFI · JAYPIRCA · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LENVIMA · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYLOTARG · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · OJJAARA · ONUREG · OPDIVO · OPDUALAG · OXBRYTA · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · PROMACTA · PROVENGE · PYRUKYND · Pedmark · Pomalyst · QINLOCK · REBLOZYL · RETEVMO · Revlimid · Rubraca · SARCLISA · SCEMBLIX · SOMATULINE DEPOT · SUTENT · Soltamox · Stivarga · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TEPMETKO · TIBSOVO · TUKYSA · Tazverik · Tecentriq · Tibsovo · Trodelvy · ULTOMIRIS · Udenyca · Ultomiris · VENCLEXTA · VERZENIO · VOTRIENT · VYXEOS · Venclexta · Vonjo · XALKORI · XARELTO · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · Yescarta · ZEJULA · ZEPZELCA · Zoladex
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (71%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 5% for internal medicine in IL.
Geographic Context
Internal medicine physicians within 10 mi
5,371
Per 100K population
103.6
County median income
$81,797
Nearest hospital
NORTHWEST COMMUNITY HOSPITAL 1
1.9 mi
1.9 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. McKian is a mixed practice specialist, with above-average Medicare volume (top 0% in IL), with low-engagement industry engagement in the top 5% of IL peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. McKian experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. McKian performed 35,250 iron infusion (injectafer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. McKian receive payments from pharmaceutical companies?
Yes. Dr. McKian received a total of $15,860 from 77 companies across 597 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. McKian's costs compare to other internal medicine physicians in Rolling Meadows?
Dr. McKian's average Medicare payment per service is $7. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. McKian) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Rolling Meadows
Browse internal medicine physicians in Rolling Meadows ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in IL
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in IL
Which IL internal medicine physicians receive the most from drug and device companies.
By company
TESARO, Inc. Payments to Doctors
See all physicians who received payments from TESARO, Inc.
By company
BeiGene USA, Inc. Payments to Doctors
See all physicians who received payments from BeiGene USA, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology